Global Parkinson's Disease Therapeutics Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID :QYR-14047211 | Published Date: 29-May-2019 | No. of pages: 104Description
TOC
Table of Contents
Parkinson's Disease Therapeutics Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Parkinson's Disease Therapeutics
1.1 Parkinson's Disease Therapeutics Market Overview
1.1.1 Parkinson's Disease Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Parkinson's Disease Therapeutics Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Parkinson's Disease Therapeutics Market by Type
1.3.1 Medications Therapeutics
1.3.2 Medical Devices Therapeutics
1.4 Parkinson's Disease Therapeutics Market by End Users/Application
1.4.1 Under 40 Years Old
1.4.2 40-65 Years Old
1.4.3 Above 65 Years Old
2 Global Parkinson's Disease Therapeutics Competition Analysis by Players
2.1 Parkinson's Disease Therapeutics Market Size (Value) by Players (2018 and 2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 GSK
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Parkinson's Disease Therapeutics Revenue (Value) (2014-2019)
3.1.5 Recent Developments
3.2 Novartis
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Parkinson's Disease Therapeutics Revenue (Value) (2014-2019)
3.2.5 Recent Developments
3.3 Boehringer Ingelheim
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Parkinson's Disease Therapeutics Revenue (Value) (2014-2019)
3.3.5 Recent Developments
3.4 Teva Pharmaceutical
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Parkinson's Disease Therapeutics Revenue (Value) (2014-2019)
3.4.5 Recent Developments
3.5 Abbvie
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Parkinson's Disease Therapeutics Revenue (Value) (2014-2019)
3.5.5 Recent Developments
3.6 Merck
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Parkinson's Disease Therapeutics Revenue (Value) (2014-2019)
3.6.5 Recent Developments
3.7 Akorn
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Parkinson's Disease Therapeutics Revenue (Value) (2014-2019)
3.7.5 Recent Developments
3.8 Kyowa Hakko Kirin Pharma
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Parkinson's Disease Therapeutics Revenue (Value) (2014-2019)
3.8.5 Recent Developments
3.9 Astellas Pharma
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Parkinson's Disease Therapeutics Revenue (Value) (2014-2019)
3.9.5 Recent Developments
3.10 Desitin Arzneimittel
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Parkinson's Disease Therapeutics Revenue (Value) (2014-2019)
3.10.5 Recent Developments
3.11 Endo Pharmaceuticals
3.12 F.Hoffmann-La Roche
3.13 H.Lundbeck
3.14 Valeant
3.15 Apokyn
3.16 Orion
3.17 Stada Arzneimittel
3.18 US WorldMeds
3.19 Valeant Pharmaceuticals
4 Global Parkinson's Disease Therapeutics Market Size by Type and Application (2014-2019)
4.1 Global Parkinson's Disease Therapeutics Market Size by Type (2014-2019)
4.2 Global Parkinson's Disease Therapeutics Market Size by Application (2014-2019)
4.3 Potential Application of Parkinson's Disease Therapeutics in Future
4.4 Top Consumer/End Users of Parkinson's Disease Therapeutics
5 North America Parkinson's Disease Therapeutics Development Status and Outlook
5.1 North America Parkinson's Disease Therapeutics Market Size (2014-2019)
5.2 North America Parkinson's Disease Therapeutics Market Size and Market Share by Players (2018 and 2019)
6 Europe Parkinson's Disease Therapeutics Development Status and Outlook
6.1 Europe Parkinson's Disease Therapeutics Market Size (2014-2019)
6.2 Europe Parkinson's Disease Therapeutics Market Size and Market Share by Players (2018 and 2019)
7 China Parkinson's Disease Therapeutics Development Status and Outlook
7.1 China Parkinson's Disease Therapeutics Market Size (2014-2019)
7.2 China Parkinson's Disease Therapeutics Market Size and Market Share by Players (2018 and 2019)
8 Rest of Asia Pacific Parkinson's Disease Therapeutics Development Status and Outlook
8.1 Rest of Asia Pacific Parkinson's Disease Therapeutics Market Size (2014-2019)
8.2 Rest of Asia Pacific Parkinson's Disease Therapeutics Market Size and Market Share by Players (2018 and 2019)
9 Central & South America Parkinson's Disease Therapeutics Development Status and Outlook
9.1 Central & South America Parkinson's Disease Therapeutics Market Size (2014-2019)
9.2 Central & South America Parkinson's Disease Therapeutics Market Size and Market Share by Players (2018 and 2019)
10 Middle East & Africa Parkinson's Disease Therapeutics Development Status and Outlook
10.1 Middle East & Africa Parkinson's Disease Therapeutics Market Size (2014-2019)
10.2 Middle East & Africa Parkinson's Disease Therapeutics Market Size and Market Share by Players (2018 and 2019)
11 Market Forecast by Regions, Type and Application (2019-2025)
11.1 Global Parkinson's Disease Therapeutics Market Size (Value) by Regions (2019-2025)
11.1.1 North America Parkinson's Disease Therapeutics Revenue and Growth Rate (2019-2025)
11.1.2 Europe Parkinson's Disease Therapeutics Revenue and Growth Rate (2019-2025)
11.1.3 China Parkinson's Disease Therapeutics Revenue and Growth Rate (2019-2025)
11.1.4 Rest of Asia Pacific Parkinson's Disease Therapeutics Revenue and Growth Rate (2019-2025)
11.1.5 Central & South America Parkinson's Disease Therapeutics Revenue and Growth Rate (2019-2025)
11.1.6 Middle East & Africa Parkinson's Disease Therapeutics Revenue and Growth Rate (2019-2025)
11.2 Global Parkinson's Disease Therapeutics Market Size (Value) by Type (2019-2025)
11.3 Global Parkinson's Disease Therapeutics Market Size by Application (2019-2025)
12 Parkinson's Disease Therapeutics Market Dynamics
12.1 Parkinson's Disease Therapeutics Market Opportunities
12.2 Parkinson's Disease Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Parkinson's Disease Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Parkinson's Disease Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
Tables & Figures
List of Tables and Figures
Figure Parkinson's Disease Therapeutics Product Scope
Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) (2014-2019)
Table Global Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Global Parkinson's Disease Therapeutics Market Share by Regions in 2018
Figure North America Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Europe Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure China Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Rest of Asia Pacific Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Central & South America Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Middle East & Africa Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Global Parkinson's Disease Therapeutics Market Share by Type in 2018
Figure Medications Therapeutics Market Size (Million USD) and Growth Rate (2014-2019)
Figure Medical Devices Therapeutics Market Size (Million USD) and Growth Rate (2014-2019)
Figure Global Parkinson's Disease Therapeutics Market Share by Application in 2018
Table Key Downstream Customer in Under 40 Years Old
Figure Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate in Under 40 Years Old (2014-2019)
Table Key Downstream Customer in 40-65 Years Old
Figure Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate in 40-65 Years Old (2014-2019)
Table Key Downstream Customer in Above 65 Years Old
Figure Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate in Above 65 Years Old (2014-2019)
Table Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2018 and 2019)
Figure Parkinson's Disease Therapeutics Market Size Share by Players in 2018
Figure Parkinson's Disease Therapeutics Market Size Share by Players in 2019
Table GSK Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of GSK (2014-2019)
Figure GSK Parkinson's Disease Therapeutics Business Revenue Market Share in 2018
Table Novartis Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Novartis (2014-2019)
Figure Novartis Parkinson's Disease Therapeutics Business Revenue Market Share in 2018
Table Boehringer Ingelheim Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Boehringer Ingelheim (2014-2019)
Figure Boehringer Ingelheim Parkinson's Disease Therapeutics Business Revenue Market Share in 2018
Table Teva Pharmaceutical Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Teva Pharmaceutical (2014-2019)
Figure Teva Pharmaceutical Parkinson's Disease Therapeutics Business Revenue Market Share in 2018
Table Abbvie Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Abbvie (2014-2019)
Figure Abbvie Parkinson's Disease Therapeutics Business Revenue Market Share in 2018
Table Merck Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Merck (2014-2019)
Figure Merck Parkinson's Disease Therapeutics Business Revenue Market Share in 2018
Table Akorn Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Akorn (2014-2019)
Figure Akorn Parkinson's Disease Therapeutics Business Revenue Market Share in 2018
Table Kyowa Hakko Kirin Pharma Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Kyowa Hakko Kirin Pharma (2014-2019)
Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Business Revenue Market Share in 2018
Table Astellas Pharma Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Astellas Pharma (2014-2019)
Figure Astellas Pharma Parkinson's Disease Therapeutics Business Revenue Market Share in 20187
Table Desitin Arzneimittel Basic Information List
Table Parkinson's Disease Therapeutics Business Revenue (Million USD) of Desitin Arzneimittel (2014-2019)
Figure Desitin Arzneimittel Parkinson's Disease Therapeutics Business Revenue Market Share in 2018
Table Endo Pharmaceuticals Basic Information List
Table F.Hoffmann-La Roche Basic Information List
Table H.Lundbeck Basic Information List
Table Valeant Basic Information List
Table Apokyn Basic Information List
Table Orion Basic Information List
Table Stada Arzneimittel Basic Information List
Table US WorldMeds Basic Information List
Table Valeant Pharmaceuticals Basic Information List
Table Global Parkinson's Disease Therapeutics Market Size (Million USD) by Type (2014-2019)
Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2014
Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2015
Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2016
Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2017
Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2018
Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2019
Table Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application (2014-2019)
Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2014
Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2017
Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2018
Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2019
Table Top Consumer/End Users of Parkinson's Disease Therapeutics
Figure North America Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table North America Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure North America Parkinson's Disease Therapeutics Market Size Share by Players in 2018
Figure North America Parkinson's Disease Therapeutics Market Size Share by Players in 2019
Figure Europe Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Europe Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Europe Parkinson's Disease Therapeutics Market Size Share by Players in 2018
Figure Europe Parkinson's Disease Therapeutics Market Size Share by Players in 2019
Figure China Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table China Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure China Parkinson's Disease Therapeutics Market Size Share by Players in 2018
Figure China Parkinson's Disease Therapeutics Market Size Share by Players in 2019
Figure Rest of Asia Pacific Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Rest of Asia Pacific Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Rest of Asia Pacific Parkinson's Disease Therapeutics Market Size Share by Players in 2018
Figure Rest of Asia Pacific Parkinson's Disease Therapeutics Market Size Share by Players in 2019
Figure Central & South America Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Central & South America Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Central & South America Parkinson's Disease Therapeutics Market Size Share by Players in 2018
Figure Central & South America Parkinson's Disease Therapeutics Market Size Share by Players in 2019
Figure Middle East & Africa Parkinson's Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Middle East & Africa Parkinson's Disease Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Middle East & Africa Parkinson's Disease Therapeutics Market Size Share by Players in 2018
Figure Middle East & Africa Parkinson's Disease Therapeutics Market Size Share by Players in 2019
Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Regions (2019-2025)
Table Global Parkinson's Disease Therapeutics Market Size (Million USD) by Regions (2019-2025)
Figure Global Parkinson's Disease Therapeutics Market Size Share by Regions in 2019
Figure Global Parkinson's Disease Therapeutics Market Size Share by Regions in 2025
Figure North America Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Europe Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure China Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Rest of Asia Pacific Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Central & South America Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Middle East & Africa Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Table Global Parkinson's Disease Therapeutics Market Size (Million USD) by Type (2019-2025)
Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2019
Figure Global Parkinson's Disease Therapeutics Market Size Share by Type in 2025
Table Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application (2019-2025)
Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2019
Figure Global Parkinson's Disease Therapeutics Market Size (Million USD) by Application in 2025
Companies
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Merck
Akorn
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Valeant Pharmaceuticals
- PRICE
-
$3350$6700